Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Endometriosis-extension Study
| Status: | Terminated |
|---|---|
| Conditions: | Women's Studies, Endometriosis |
| Therapuetic Areas: | Other, Reproductive |
| Healthy: | No |
| Age Range: | 18 - 48 |
| Updated: | 2/14/2019 |
| Start Date: | February 28, 2009 |
| End Date: | August 31, 2009 |
A Randomized, Double-blind Study Evaluating the Safety and Efficacy of Proellex® in the Treatment of Premenopausal Women With Symptomatic Endometriosis-extension Study
ZPE-201 Extension of treatment
This is an extension of the phase II, three-arm, parallel design, dose-ranging,
placebo-controlled, randomized, double-blind, multicenter study in which placebo or one (1)
of two (2) dose levels of Proellex® was administered once-daily for four (4) months.
placebo-controlled, randomized, double-blind, multicenter study in which placebo or one (1)
of two (2) dose levels of Proellex® was administered once-daily for four (4) months.
Inclusion Criteria:
- Only subjects treated in the ZPE-201 study will be allowed to enter the extension
study.
- Subjects who withdrew from ZPE-201 due to lack of treatment efficacy will also be
invited to participate.
Exclusion Criteria:
- All other subjects
We found this trial at
8
sites
7940 Floyd Curl Drive
San Antonio, Texas 78229
San Antonio, Texas 78229
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials